Prevention and Screening Towards Elimination of Cervical Cancer

NACompletedINTERVENTIONAL
Enrollment

30,000

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

December 30, 2023

Study Completion Date

January 31, 2024

Conditions
HPV InfectionCervix CancerCervical Dysplasia
Interventions
BEHAVIORAL

Community mobilisation for hrHPV self-testing

use of social media, written media, theatre and other sources of communication to reach women, and relatives, to convince them of importance of screening.

DIAGNOSTIC_TEST

hrHPV self-testing

use of swabs that women insert in the vagina for taking sufficient material for testing for hrHPV. For women who are not confident to perform this this nurses provide assistance.

BEHAVIORAL

Follow-up after testing

based on the results of the test, follow-up is offered. In case of hrHPV negative test, retesting after five years. In case of hrHPV positive test, VIA in a nearby clinic. Women have to be motivated to adhere to follow-up

DIAGNOSTIC_TEST

VIA

Test offers insight into existence of dysplasia of the cervix by colouring the transition area

PROCEDURE

Thermo-ablation or cryotherapy for dysplasia

Women with identified dysplasia lesions are offered immediate therapy to remove the infected superficial surface of the cervix

DIAGNOSTIC_TEST

Pap smear cytology

Cytology for identification of abnormal cells in the cervix, and classification of stages of dysplasia or pre-cancerous lesions

Trial Locations (1)

Unknown

Mpasana, Kakumiro

All Listed Sponsors
collaborator

Trnavska Universita v Trnavě

UNKNOWN

collaborator

Uganda Cancer Institute

OTHER

collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

collaborator

Manipal Academy for Higher Education

UNKNOWN

collaborator

Female Cancer Foundation

UNKNOWN

lead

University Medical Center Groningen

OTHER